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The evaluation of a 2D diode array in "magic phantom" for use in high dose
rate brachytherapy pretreatment quality assurance
Abstract

Purpose: High dose rate (HDR) brachytherapy is a treatment method that is used increasingly worldwide.
The development of a sound quality assurance program for the verification of treatment deliveries can be
challenging due to the high source activity utilized and the need for precise measurements of dwell positions
and times. This paper describes the application of a novel phantom, based on a 2D 11 x 11 diode array
detection system, named "magic phantom" (MPh), to accurately measure plan dwell positions and times,
compare them directly to the treatment plan, determine errors in treatment delivery, and calculate absorbed
dose. Methods: The magic phantom system was CT scanned and a 20 catheter plan was generated to simulate
a nonspecific treatment scenario. This plan was delivered to the MPh and, using a custom developed software
suite, the dwell positions and times were measured and compared to the plan. The original plan was also
modified, with changes not disclosed to the primary authors, and measured again using the device and
software to determine the modifications. A new metric, the "position-time gamma index," was developed to
quantify the quality of a treatment delivery when compared to the treatment plan. The MPh was evaluated to
determine the minimum measurable dwell time and step size. The incorporation of the TG-43U1 formalism
directly into the software allows for dose calculations to be made based on the measured plan. The estimated
dose distributions calculated by the software were compared to the treatment plan and to calibrated EBT3
film, using the 2D gamma analysis method. Results: For the original plan, the magic phantom system was
capable of measuring all dwell points and dwell times and the majority were found to be within 0.93 mm and
0.25 s, respectively, from the plan. By measuring the altered plan and comparing it to the unmodified
treatment plan, the use of the position-time gamma index showed that all modifications made could be readily
detected. The MPh was able to measure dwell times down to 0.067 ± 0.001 s and planned dwell positions
separated by 1 mm. The dose calculation carried out by the MPh software was found to be in agreement with
values calculated by the treatment planning system within 0.75%. Using the 2D gamma index, the dose map of
the MPh plane and measured EBT3 were found to have a pass rate of over 95% when compared to the original
plan. Conclusions: The application of this magic phantom quality assurance system to HDR brachytherapy
has demonstrated promising ability to perform the verification of treatment plans, based upon the measured
dwell positions and times. The introduction of the quantitative position-time gamma index allows for direct
comparison of measured parameters against the plan and could be used prior to patient treatment to ensure
accurate delivery.
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Purpose: High dose rate (HDR) brachytherapy is a treatment method that is used increasingly
worldwide. The development of a sound quality assurance (QA) program for the verification of
treatment deliveries can be challenging due to the high source activity utilized and the need for
precise measurements of dwell positions and times. This paper describes the application of a novel
phantom, based on a two dimensional 11x11 diode array detection system, named “magic phantom”,
to accurately measure plan dwell positions and times, compare them directly to the treatment plan,
determine errors in treatment delivery and calculate absorbed dose.
Methods: The “magic phantom” (MPh) system was CT scanned and a 20 catheter plan was generated
to simulate a nonspecific treatment scenario. This plan was delivered to the MPh and, using a custom
developed software suite, the dwell positions and times were measured and compared to the plan. The
original plan was also modified, with changes not disclosed to the primary authors, and measured
again using the device and software to determine the modifications. A new metric, the “position-time
gamma index”, was developed to quantify the quality of a treatment delivery when compared to the
treatment plan. The MPh was evaluated to determine the minimum measurable dwell time and step
size. The incorporation of the TG-43U1 formalism directly into the software allows for dose
calculations to be made based on the measured plan. The estimated dose distributions calculated by

the software were compared to the treatment plan and to calibrated EBT3 film, using the 2D gamma
analysis method.
Results: For the original plan, the “magic phantom” system was capable of measuring all dwell points
and dwell times and the majority were found to be within 0.93 mm and 0.25 s, respectively, from the
plan. By measuring the altered plan and comparing it to the unmodified treatment plan, the use of the
position-time gamma index showed that all modifications made could be readily detected. The MPh
was able to measure dwell times down to 0.067 ± 0.001 s and planned dwell positions separated by 1
mm. The dose calculation carried out by the MPh software was found to be in agreement with values
calculated by the treatment planning system within 0.75%. Using the 2D gamma index, the dose map
of the MPh plane and measured EBT3 were found to have a pass rate of over 95% when compared to
the original plan.
Conclusions: Our application of the “magic phantom” quality assurance system to HDR
brachytherapy has demonstrated promising ability to perform the verification of treatment plans,
based upon the measured dwell positions and times. The introduction of the quantitative position-time
gamma index allows for direct comparison of measured parameters against the plan, and could be
used prior to patient treatment to ensure accurate delivery.
1. Introduction
Due to the severe consequences associated with the incorrect delivery of High Dose Rate (HDR)
brachytherapy treatments, it is essential that the measurement of source dwell times and verification
of dwell location can be undertaken with high precision. Human and calculation errors introduced
during the treatment planning and preparation processes, in addition to incorrect calibration of the
HDR afterloader, can potentially lead to incorrect dwell location and timing during treatment,
resulting in the misadministration of dose to the treatment volume1,2,3.
Brachytherapy treatment planning systems (TPS) employ algorithms based on the AAPM TG-43U1
protocol4 to calculate dose distributions around the HDR source, and to plan the necessary treatment.
Since the treatment relies on the correct delivery of the plan by the HDR remote afterloader, it is

desirable to develop an independent quality assurance (QA) method that accurately verifies the HDR
source dwell positioning and timing pattern for each catheter. A sound QA program should include a
pre-treatment plan verification5 and would give confidence of a correct execution at the time of
treatment. Although the afterloader has high precision in its control of the source movement,
treatment outcomes of plans with multiple catheters are more susceptible to deviations in dwell
position and time6.
There have been efforts found within the literature to develop a method for verification of planned
dwelling and timing patterns before and during treatment. These include pinhole imaging7,8, diamond
detectors9, flat panel10 and EPIDs11, film and photodiodes12, ion chamber arrays13 and video cameras*.
These devices, while capable of source tracking, can be costly and are limited in their ability to
perform a quick, comprehensive and automated analysis of a full treatment plan.
The feasibility study of a two dimensional detector array “magic plate”, housed inside a “magic
phantom” (MPh), showed the “magic plate” to be capable of determining the source position within
three dimensions with a fast acquisition speed (0.1 – 100 ms)14. This work seeks to evaluate the proof
of concept performance of the novel MPh, with updated electronics and software toolkit, as a
complete system for HDR pre-treatment plan and afterloader verification. We aim to show that the
MPh has the potential to accurately measure the dwell positions and times of any treatment, compare
those measured values against the treatment plan, determine any errors in delivery, and estimate the
total dose delivered - including the transit dose contribution along the “magic plate” plane.
The MPh system was CT scanned and using ONCENTRA® TPS (Nucletron, the Netherlands), two
20 catheter treatment plans were created. The treatment plans were measured using the MPh and the
dwell positioning and timing were evaluated based on a new acceptance criterion for HDR QA,
named the position-time gamma index. Dose distributions were calculated by the developed software,

*

Mick Radio-Nuclear Instruments, Inc., Mount Vernon, NY, USA, accessed: 11th of August 2014 (available

URL: http://www.micknuclear.com/home/products/quality_assurance_tools.html)

mpared to thhe treatment plan and E
EBT3 film measurement
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s using the 2D gamma analysis
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proposedd by Low et al15.
2. Materials
The “maagic phantom
m”, MPh, is the
t HDR speecific casing for the silicon-based dettector system
m “magic
plate”. T
The “magic plate”
p
consissts of 121 p -type silicon
n epitaxial diiodes in an 111x11 array,, and has
been chaaracterized for
f use in IM
MRT/VMAT
T radiation th
herapy16 and
d HDR brachhytherapy14. Both the
“magic plate” and “magic
“
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n Physics
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l
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Figure 1 - Illustration and
a photo of the "magic plate"" inside the MPh
h, with slabs off Solid Water abbove and below
w. On the
right, the HDR catheters witthin the MPh arre seen to be atttached to the HD
DR afterloader transfer tubes.

The MP
Ph consists of
o three 1 cm
m slabs of P
PMMA plasttic, with an area of 30x330 cm2. PM
MMA was
chosen aas material for
f this geneeration of thhe MPh due its optical trransparency,, which assissted with
preliminnary positionnal calibratiions. It is nnoted that while
w
this material
m
is not well su
uited for

king methodd is based on
n the detecto
ors response within this phantom
dosimetrry18,19,20, the source track
and has been previoously charactterized14. Latter versions will be completely madee of Solid Water.
W
An
illustratiion and photoo are seen in
n Figure 1.
The “m
magic plate” was
w inserted into the midddle slab of the
t MPh, plaacing the 10xx10 cm2 field
d of view
(FOV) oof the detecttors directly in the centeer of the ph
hantom. The top and botttom layers have ten
15x2x2 mm3 channeels machined
d onto the booundary to th
he center slab
b, allowing fo
for the insertiion of 20
HDR pllastic catheteers. A thickn
ness of 13.5 cm of waterr equivalent material waas placed bo
oth above
and beloow the MPh, to ensure baackscatteringg conditions were
w met.

Figure 2 - Illustration of catheter channeels with respectt to the “magic plate”. White squares
s
represennt diode positio
ons relative
to cathheters with the two
t rows of cattheters above (bblack), and belo
ow (grey). The left shows a topp view of the caatheters
insertted into the MPhh with respect to
t the detectors position and th
he x and y-coordinate origin onn a corner detecctor, as
indicated byy a cross. The right shows the sside view of thee MPh with the catheters numbbered 1 to 20.

Two row
ws of 10 catheters were inserted intoo the trenchees approximaately 6 mm aabove and below
b
the
“magic plate” array. The catheter trenches w
were spaced
d at 10 mm apart with thhe above row
w placed
betweenn the columnns of the MPh
h detector arrray, and the below row directly alignned with thee detector
columnss, shown in Figure 2. Using
U
a corneer detector as
a the origin
n of the MPhh coordinatee system,
indicatedd by a crosss inside the detector, thhe catheters are at z = ± 6 mm, and
nd at an x-co
oordinate
correspoonding to thhe catheter columns, witth the cathetter length along the y-co
coordinate. Using
U
the
result oof the sourcce tracking algorithm aat each fram
me of measurement, thhe x-y-z co
oordinate
measureement of the source was translated
t
to catheter num
mber and possition within the catheter..

All 121 MPh detectors were read out by an in-house designed front-end electronics system, named
“AFE data acquisition system” (AFE DAQ)21,22. The system uses two Texas Instrument commercial
electrometer AFE-0064 chips and is controlled by a CMRP designed FPGA master board. The timing
of the system is accurately governed by a 20 MHz master clock on the FPGA board and has an
estimated error in timing of 50 ns. This communicates to the PC via USB2.0, and is controlled by an
in-house designed firmware. The AFE DAQ is capable of a variable integration time (between 14 to
9900 μs), with a stable sampling frequency of 0.1 to 10 kHz, and allows for triggering from external
sources for linear accelerator measurements or using an internal trigger signal. For this work, a 1 kHz
sampling frequency and 100 μs integration time was used for all measurements.
A custom software interface was developed in C++ to: a) communicate with the FPGA and drive the
AFE DAQ; b) perform source tracking in real time and in post-processing; c) perform dwell position
and timing analysis; and d) calculate the absorbed dose from the TG-43U1 protocol based on
measured source dwelling position and time and compare it to the dose prescribed by the treatment
plan. The system and software measures the charge generated in all 121 MPh detectors within the
integration time, at a periodic sampling frequency. The response at each measurement frame for each
detector was collected in a data file for post-processing.
The software performs TG-43U14 dose calculations to predict the dose generated to the MPh plane,
based upon the measured dwell position analysis, the HDR

192

Ir Flexisource specifications23 and

known source activity. This was compared to the dose predicted by the TPS for selected points, and
dose maps were generated and verified experimentally using Gafchromic EBT3 film. Due to the
manufacturers stated dose range of “1 cGy to > 40 Gy”†, the tested dose range of up to 90 Gy24 and
relatively weak energy dependence for energies as low as 50 keV25,26, the use of Gafchromic EBT3
appears well suited for use in 192Ir HDR dosimetry and plan verification.

†

Ashland International Specialty Products (ISP) Advanced Materials, New Jersey, USA, Gafchromic EBT3

product brochure (2011).

The MPh was imaged using the CT scanner, and the images imported into the Nucletron
ONCENTRA® TPS. Each small MPh detector element could be seen on the 3D image reconstruction,
with each detector selected as a point for dose calculations. The source was programmed to dwell at
various positions and times inside each of the 20 catheters to create a nonspecific treatment plan with
a maximum dose of 600 cGy to a single detector element. Each catheter had varying dwell positions
and times arranged in the plan in an unsystematic fashion.
A copy of the plan was created and modified by a member of the hospital medical physics staff,
without the supervision of the authors, and an undisclosed number of changes were made. The plan
was altered by the inclusion of new dwell points, points shifted or removed, and dwell times
lengthened or shortened, to simulate a scenario where there is a misadministration by the afterloader.
Each plan was exported as a DICOM file, preserving the source dwell and timing information for each
catheter and the calculated absorbed dose at each detector position on the MP. Both DICOM plan files
were subsequently read by the custom software suite; first to compare the measured dwelling
position-time pattern with the original plan and identify the modifications using the position-time
gamma analysis, and then to verify that all alterations measured were indeed made within the
modified plan. All plans were delivered using the Flexitron HDR afterloader (Nucletron, the
Netherlands) at the St George Cancer Care Centre, Sydney.
3. Methods
3.A. Determination of source dwell positions and dwell times
A method for determining the HDR

192

Ir source position using a two dimensional detector array was

introduced within the “magic plate” feasibility study14. It is based on the sampled dose rate
measurements from the nine neighboring diodes with the largest signals, followed by an iterative
optimization procedure that takes into account the angular response of the diodes27. This method
calculates, for each frame of measurement, the x-y-z coordinates of the HDR source when in the FOV
of the MPh detectors. Building upon these results, the software interface was designed to
automatically determine the source dwell positions and dwell times from the treatment measurement.

Time gaps between the last position of each catheter and the first dwell of the next catheter do not
affect the source position determination, as there is extremely little signal when the source is outside
of the phantom. When the maximum signal during a measurement frame is below a predetermined
threshold level, the software does not execute the source position calculation algorithm. The threshold
level is dependent on the expected range of source activity and corresponds to the estimated current
generated within a detector by a source at a distance of 150 mm away in the z direction, inside the
FOV of the MPh. The noise level is very low in this developed system, and consequently, has
minimal bearing on measurements.
The unmodified 20 catheter plan delivery was measured using the MPh and the source position was
analyzed in post-processing. For each catheter, a position-frequency histogram was generated from
the source tracking data. The sampled source position was binned and peaks appeared in the
histogram when many measurements occurred at the same position, i.e. when the source was
dwelling. The number of counts under each peak of the histogram corresponds to the measured dwell
time, as the time for each count was dependent on the sampling frequency of the system. The dwell
position and uncertainty was determined by the center and full width half maximum (FWHM) of the
peak. These results were compared to the dwell position and times found within the treatment
planning file.
The position of the source is related to the tip of each catheter, which is registered in the frame of the
MPh with coordinate system origin based on a left corner detector. A position calibration test, relative
to the MPh origin, was performed by driving the source at multiple positions within a single catheter
and simultaneously measuring with the MPh and exposing EBT3. The EBT3 film was registered to
the MPh by fixing it rigidly between the “magic plate” and top catheter plane. The center of mass of
each source image on the film and the dwell positions calculated by the software were compared with
the planned dwell position. The planned dwell positions were based on the CT scan of the MPh with
tip markers inside each catheter.
3.B. Determination of the minimum measurable step size and dwell time

The Flexitron HDR afterloader can be programmed to drive the HDR source using varying step sizes
and dwell times, with a minimum of 1 mm and 0.1 s, respectively. To be feasible for plan verification,
the MPh system must be able to determine dwell positions and times accurately, over this range of
step sizes and dwell times.
To assess the dwell position resolution of the system, the afterloader was programmed to deliver the
HDR source through a single catheter, moving with progressively reduced step sizes down to 1 mm.
Each dwell position had a programmed dwell time of 3 s and was measured using the MPh system.
The transit time of the source from one dwell position to the next was also measured.
To assess the dwell time resolution of the system, the HDR afterloader was programmed to drive the
source to 3 dwell positions within a single catheter for the same amount of time. The measurement
was repeated for a range of dwell times from 10 s down to 0.1 s.
3.C. Position-time gamma index
To quantitatively compare the source position and dwell times within the catheter to the treatment
plan, a new metric is introduced based upon the dose-position gamma index. The use of the 2D
gamma index in QA was first described by Low et al15 and was used to quantitatively compare dose
distributions for external beam radiation therapy. It compares the dose difference, point-by-point, and
the distance-to-agreement between the evaluated dose distribution and that of the reference dose
distribution, and is used for analysis in sections 3.E and 4.E.
Adopting the formalization of this method and applying it to HDR brachytherapy, it is possible to
compare the measured treatment to the plan by evaluating the source dwell and timing patterns. By
using acceptable distance-to-agreement and time-to-agreement criteria values, a pass-fail grade (pass
if gamma value is equal to or less than 1) is determined for all measured dwell positions and times.
Table 1 - Definition of symbols used for HDR position-time gamma index.

Symbol
,

Equation
N/A

Description
The i-th dwell position,

, and dwell

time,
N/A

,

, of set A within catheter n.

The j-th dwell position,
time,

, and dwell

, of set B within catheter n.

∆

N/A

Distance-to-agreement criterion (DTA).

∆

N/A

Time-to-agreement criterion (TTA).

,

is the spatial difference between the

,

i-th dwell position of set A and the j-th
dwell position of set B for catheter n.
,

is the difference between the i-th

,

dwell time of set A and the j-th dwell
time of set B for catheter n
,
,

,

,

∆

∆

Generalized

index computed for all

dwell positions and times of set A and
set B for catheter n.

,

∀

,

The

index - the minimum generalized
,

for the set B,

dwell

positions and dwell times within catheter
n.

The formalization of this method is found in Table 1. Two sets, A and B, represent the measured and
TPS dwell position timing patterns within catheter n. The gamma index compares the dwell positions
within set B against those in set A. The gamma index was calculated twice; first to compare the
treatment measured by the MPh (set B) against the treatment plan (set A), and then to compare the
treatment plan (set B) against the measured (set A). This increases the robustness of the method,
taking into account cases when sets A and B have unequal numbers of dwell positions due to positions
introduced or missed by the afterloader. A graphical representation of the position-time criteria is seen
in Figure 3.

Figure 3 - Geometric reppresentation of the
t position-tim
me criteria. Dweell points insidee or on the ellippsoid have a gam
mma value
equal or leess than 1 and pass
p the criteriaa. Outside this eellipsoid, the gaamma index vallue is greater thhan 1 and fails the criteria.

3.D. Possition-time gamma
g
indeex on modifiied plan
The modified versioon of the plaan was meassured by thee MPh and the
t results w
were compareed to the
original plan. The modified
m
plan had an undiisclosed num
mber of chang
ges made by medical phy
ysicists to
simulatee an incorrecct treatment delivery. Thhis was tested to verify the positionn-time gamm
ma index
analysis method. Foollowing the software annalysis of the measurement, the moddified treatm
ment plan
DICOM
M file was reaad to verify th
hat all the altterations werre correctly identified.
i
3.E. Coomparisons between “magic
“
phaantom” calcculated dose, TPS andd EBT3 film dose
measureements
The softtware suite performs
p
dose calculationns based upo
on the TG-43
3U1 formalissm, and was tested to
ensure thhat calculations agreed with
w doses prrescribed by
y the TPS. Eaach MPh dettector coordiinate was
selected for point doose calculatiions and storred inside th
he DICOM file,
f
along w
with the sourrce dwell
positions and times. A direct co
omparison beetween the values
v
within
n the DICOM
M was performed for
121 poinnts using the dose calculaation engine of the software.
Gafchroomic EBT3 film
f
(Ashland
d ISP Advannced Materiaals, USA) lott #A071513002 was used to verify
the dosee calculated by
b the TPS and
a by the cuustom softw
ware suite. Prrior to this m
measurement,, the film
was callibrated by exposing fiive 10x10 ccm2 pieces to the HD
DR
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Ir souurce. The MPh
M
was

disassembled and the top layer with catheter trenches was placed within a 30x30x30 cm2 Solid Water
stack. A single piece of film was placed at the center of the stack, and a single catheter was inserted
into a trench directly over the film, at an approximate source-to-film distance of 16 mm.
ONCENTRA® TPS was used to calculate the necessary time to deliver a dose to the center of the
film, with the 5 pieces of film irradiated to 100, 200, 400, 600 and 1000 cGy using a single dwell
position.
All pieces of film were pre-scanned and post-irradiation scanned using a 48-bit RGB transmission
film scanner, the EPSON 10000XL, at a resolution of 300 dpi, with no color or sharpness corrections
and at a consistent orientation and position to the scanner. Approximately 72 hours passed between
film irradiation and scanning to ensure the film response had stabilized. The calibration films were
scanned and the image files were measured using IMAGEJ (version 1.47v). Six consecutive scans
were performed for each piece of film to ensure consistent performance of the scanner on the last
three used for analysis. A calibration curve was generated for the red color channel based upon the
largest change in optical density and exposed dose. The total uncertainty was calculated to be
approximately 6.1% (1 S.D), based upon an uncertainty budget which considers the source-to-film
position, scanner inhomogeneity and reproducibility and the TPS dose calculations and source activity
measurements.
Using the software, dose maps were generated along the MPh detector plane for the original treatment
plan, the measured treatment based upon the measured dwell positions and times, and for the modified
treatment plan. The original treatment plan was then measured by replacing the “magic plate” detector
with EBT3 film. The film was cut to match the size of the “magic plate” and markings were made for
alignment. Both the film and “magic plate” were later scanned using the scanner, so that the film dose
map positions could be registered to those calculated by the MPh software. The change in optical
density was converted to dose using the calibration curve. The dose maps were then compared using
the 2D gamma analysis, with varying dose difference and distance-to-agreements criteria. Each map
had a size of 10x10 cm2, with pixel dimensions of 0.5x0.5 mm2.

The total transit dose for the MPh diode positions was also estimated by performing dose calculations
for each measured source position between dwell positions, assuming a discrete source movement
between consecutive frames.
4. Results
4.A. Determination of source dwell positions and dwell times
Figure 4 shows the calculated source position and dwell time in a position within the first catheter
verses time, determined by the algorithm described in detail in previous study14. It can be seen that the
source travels from the afterloader and dwells at the furthest dwell position away from the catheter tip,
and moves progressively closer. The TPS plan for this catheter is graphed for comparison and shows
good agreement for positions larger than 5 mm from the coordinate origin based on the MPh corner
detector. While the TPS does not take into account the motion of the source in transit between dwell
points, it is possible to measure this due to the high speed of the MPh readout system.
The last two dwell positions were close to the catheter tip and the edge of the FOV of the “magic
plate”, and used fewer detectors for calculation of source position. As the source tracking algorithm is
based upon the agreement of the detector with the largest response and its neighbors, reduced
numbers of detectors can result in a shift in true position. For accurate source dwell position
calculations, the TPS plan should be configured to set the last dwell points at least 5-10 mm away
from the edge of the MPh FOV. While there is a reduction in useable catheter length for this particular
design of “magic plate”, it will be possible to measure the dwell position accurately within a range of
80-90 mm. This issue was considered for the design of the next generation of the “magic plate”, MP512, which features a larger area, 512 diodes and a 5 mm pitch between detectors.

Figure 4 - Source tracking measurement and TPS plan for

Figure 5 - Measured dwell position frequency histogram for

Catheter 1. The position calculated was relative to the MPh

Catheter 1. The net area of each peak corresponds to the

coordinate system.

total dwell time at the position. Each count represents 1 ms
due to measurement frequency.

A position frequency histogram was generated from the source tracking calculations for each catheter.
Each histogram had a bin width of 0.1 mm and the counts of source position were related to the
electronic sampling frequency. Each count within the histogram represented 1 ms of time that the
source had spent at that calculated position. Figure 5 shows the histogram for Catheter 1. Each dwell
point was seen to be a narrow peak, where the center was equal to the dwell position and the FWHM
was the uncertainty of position. The number of counts converted to time under each peak is equal to
the total dwell time for that dwell position.
The calculated and TPS planned dwell position-time patterns for catheter 1 are also presented in
Figure 6. Uncertainties in the dwell positions were typically of the order of 0.2 mm (2 S.D) and are
unable to be seen on this graph. Good agreement between these dwell patterns were seen for the
majority of points, except for those close to 0 mm, due to the edge of FOV effect. The dwell positions
and times were compared to the treatment plan.

Figure 6 – Dwell position frequency histogram and

Figure 7 - Difference between the measured and planned

comparison of dwell position timing pattern for Catheter 1

dwell positions for the MPh calculation and EBT3 film for

with the TPS plan. The circles show the total dwell time

single catheter measurement.

calculated from the corresponding peak at that position.

Figure 7 shows the difference along the catheter length between the measured and planned dwell
positions for the position calibration test. The source was driven through a single catheter towards the
catheter tip and the EBT3 film was irradiated, while the MPh measured. Six dwell positions were
identified by both the software and the film analysis with all differences less than 0.8 mm. An
uncertainty of ± 0.25 mm (2 S.D) was estimated due to the coordinate registration of the film to the
MPh reference frame.

Figure 8 - Histogram showing the difference in dwell times

Figure 9 - Difference between measured and planned dwell

of the Measured and TPS.

times against interdwell distance.

The average difference between the measured dwell position and the TPS plan for 86 dwell positions
was 0 ± 0.63 mm (2 S.D), taking into account the larger differences due to the edge of FOV effect.

Seen in Figure 8, the dwell time differences were found to be less than 0.25 s, and the majority
showed that the MPh measured less than the expected planned dwell times. It is expected that due to
the highly accurate internal clock of the electronics used, the error in timing is extremely small.
This difference in dwell time is most likely due to a feature of the Flexitron afterloader that reduces
dwell times to compensate for additional dose delivered while the source is in transit between
successive dwell points. In Figure 9, the differences in dwell times are plotted against the interdwell
distances (the distance between two dwell positions), showing that the difference in dwell time for the
subsequent position is proportional to the distance the source had to travel. An interdwell distance of 0
mm represents the first dwell position within the catheter, where it is expected that there will be no
change in dwell time.
According to the ONCENTRA® MasterPlan Physics and Algorithms manual‡, it is assumed that this
afterloader drives the source at a speed of 50 cm/s and for an interdwell distance of 50 mm the dwell
time is reduced by a maximum of 0.1 s. It is noted that this feature may not be seen in some
afterloaders. The measured dwell time differences are larger than expected but, as seen in the
feasibility study for the “magic plate” detector, the average source speed was measured and found to
vary from 12.5 to 37.5 cm/s based on interdwell distance14. Although a different afterloader was used
for the feasibility study, if it is assumed they share similar average source speeds, the variation in
dwell time difference can be justified.
4.B. Determination of the minimum measurable interdwell distance and dwell time
The HDR source was driven to 9 dwell positions in a single catheter, with spaces between dwell
positions varying from 30 mm to 1 mm. As seen in Table 2, the dwell positions were determined by
the MPh, and the system was capable of resolving the dwell positions separated by 1 mm. There is
some deviation noted between dwell positions, which may be due to the edge of FOV effect
‡

Oncentra MasterPlan v3.2, Physics and Algorithms Manual, 192.739ENG-02, Nucletron, the

Netherlands.

previously discussed. The dwell times for each position were found to follow the trend of reduced
times, as a function of interdwell distance (Figure 9) and agreed with the determined transit times.
Table 2 – Comparison of the planned position in an HDR catheter and the position and time measured using the MPh.

Planned position (mm)

Measured position (mm)

Measured dwell time (s)

Measured transit time (s)

(± 0.001 s)

(± 0.001 s)

83.6

83.49 ± 0.14

3.015

-

53.6

53.82 ± 0.12

2.792

0.219

33.6

34.23 ± 0.14

2.849

0.172

23.6

23.95 ± 0.18

2.919

0.109

18.6

18.27 ± 0.16

2.946

0.066

14.6

15.06 ± 0.16

2.987

0.040

11.6

11.54 ± 0.16

2.976

0.054

9.6

8.72 ± 0.18

2.989

0.041

8.6

7.35 ± 0.16

2.991

0.027

The minimum measurable dwell time for the MPh system was evaluated by using three dwell
positions, at 13.6 mm, 18.6 and 28.6 mm from the catheter tip, and varying the planned times. Each
position was set to have the same dwell time, but these varied when measured, except for Position 1
which was the first the source was driven to. In Table 3, it can be observed that the minimum dwell
time that was measured was 0.067 ± 0.001 s (2.SD). Following the trend of dwell time reduction, for
the planned dwell times of 0.1 s, Position 2 was expected to have a time of 0.01-0.02 s, but could not
be detected by the system due to not being distinguishable within the position frequency histogram.
Table 3 - Determination of the minimum measurable dwell time

Planned dwell time (s)

Measured dwell time (s) (± 0.001 s)

TPS

Position 1 (28.6 mm)

Position 2 (18.6 mm)

Position 3 (13.6 mm)

10

10.012

9.914

9.955

5

5.015

4.908

4.951

3

3.014

2.898

2.955

2

2.014

1.911

1.951

1

1.013

0.916

0.957

0.5

0.512

0.414

0.458

0.3

0.315

0.213

0.256

0.2

0.212

0.109

0.155

0.1

0.107

Unable to determine

0.067

The verification of the accuracy of all dwell times set by the TPS is impossible, as the afterloader
always modifies the actual dwelling time by taking the transit time into account. We have, however,
demonstrated an obvious relationship between the absolute dwell time and interdwell distance, which
is noticeable for all dwell times. This shows that the timing capabilities of this developed system
surpass the programmable limitations of the afterloader system.
4.C. Position-time gamma analysis
The software suite determines the dwell position and times for all the catheters and compares them
against the treatment plan using the position-time gamma analysis. By applying the equations
described in Table 1 to the dwell pattern of Catheter 1, the gamma index values for each dwell
position were calculated and are shown in Figure 10. Taking into account the differences between the
measured dwell position and times from section 4.A, the DTA and TTA were set to 1.3 mm and 0.3 s,
respectively. Uncertainties were calculated based on the standard deviation of the dwell position
measurement and the DTA criteria.

Figure 10 - Gamma analysis for Catheter 1 (DTA = 1.3 mm,

Figure 11 - Gamma analysis for all catheters (DTA = 1.3

TTA = 0.3 s).

mm, TTA = 0.3 s).

Applying the gamma index to all 20 catheters, it can be seen from Figure 11 that the majority of the
treatment (95%) have gamma values of less than or equal to 1. There are 5 points with gamma values
greater than 1, but they are considered to pass, due to their uncertainty.
4.D. Position-time gamma index on modified plan
The modified plan was measured using the MPh and using the results from the position-time gamma
analysis, an estimated 11 changes were expected to have been made to the treatment plan. One change
to Catheter 3, seen in Figure 12, was the addition of a dwell position. This position was seen to be at
17.2 ± 0.1 mm (2 S.D) from the coordinate origin, with a dwell time of 14 s.

Figure 12 - Comparison of dwell pattern for Catheter 3

Figure 13 - Gamma analysis for Catheter 3 for the modified

against the TPS plan. It can be seen that the MPh measures a

plan (DTA = 1.3 mm, TTA = 0.3 s). The introduced dwell

dwell position at 17.0 mm introduced within the modified

position has a gamma value of 12.0 ± 1.9.

plan.

The addition of the new dwell position causes the gamma analysis of this catheter, seen in Figure 13,
to fail the pass-fail criteria. A gamma value of 12.0 ± 1.9 (2 S.D) was calculated based on the
agreement between the additional measured position and the nearest TPS planned dwell point
(position = 24.3, time = 11.3). Comparing the position-time gamma index for the entire modified
treatment to the original plan, Figure 14 indicates 11 modified dwell positions. Upon analyzing the
modified treatment plan DICOM, these 11 alterations were verified to be the introduced changes.

Figure 14 - Gamma analysis for all catheters for the modified plan (DTA = 1.3 mm, TTA = 0.3 s). Each gamma value larger
than 1 represents a dwell position either removed or introduced into the plan.

4.E. Comparisons between “magic phantom” calculated dose, TPS and EBT3 film dose
measurements
The TPS DICOM file of the original plan was read by the MPh software, and the coordinates and
value of each dose calculation were acquired. The software subsequently recalculated the dose at the
same points using its own implementation of the TG-43U1 protocol, using the same planned
parameters. Good agreement was found between the MPh software estimated doses for the 121
positions and the TPS, with values within ± 0.75% (2 S.D) suggesting that the dose calculation engine
based on predetermined dwell positions and times is correct.
Two-dimensional 10x10 cm2 dose maps along the MPh plane were generated using the TG-43U1
calculation tool with 0.5x0.5 mm2 pixel size. These were produced for the planned and measured
source dwell positions and times of the original plan, and for the measured modified plan. The
calculated 2D dose map for the measured dwell positions and times of the original plan is shown in
Figure 15. The film was irradiated using the unmodified plan and processed to create a map with the
same dimensions and resolution as the others.

Figure 15 – Dose to the MPh detector plane calculated using

Figure 16 – The calculated total transit dose contribution,

TG-43U1, based upon measured dwell positions and times,

delivered to the MPh detector plane for the unmodified

without transit dose contribution.

treatment plan.

The MPh system was also capable of estimating the contribution of the total transit dose for this plan
by calculating the dose delivered for the sampled transit positions only. Seen in Figure 16, the total
maximum transit dose was calculated to be 18 cGy for the measured plan. This represents an average

of 4.8 ± 2.3% (2 S.D) increase in dose delivered when compared to the total dose delivered from the
dwell positions only. This result is dependent on the source activity and for this particular plan the
transit dose contribution could double when delivered directly after a source exchange, assuming the
same transit times.
All dose distributions were compared using the 2D gamma analysis for varying dose difference and
distance-to-agreement criteria, and the results are shown in Table 4. The dose difference value was
calculated based upon the maximum dose within the compared maps. It is evident that by using a dose
difference of 4% and distance-to-agreement of 3 mm, a pass rate of over 95% could be achieved for
both the MPh dose map without the transit dose and the film for the original plan. When considering
the transit dose contribution, a pass rate of over 90% for all criteria examined was obtained. This
suggests that the reduction of the dwell times is an appropriate method to compensate for the total
transit dose when executing this plan. Using lower criteria values reduced the pass rate for film, most
likely due to the registration of the film position to the MPh and the associated uncertainty in the film
dose calculation.
Table 4 – Comparison of calculated dose maps against the reference TPS planned dwell positions and times.

Gamma pass rate (%) for dose difference and distance-to-agreement criteria
Evaluated maps

2% / 2 mm

3% / 3 mm

4% / 3 mm

Measured by the MPh -

80.6

94.0

98.3

90.6

98.3

99.9

58.7

82.2

95.8

original plan
Measured by the MPh original plan with
transit dose
EBT3 film – original
plan

Measured by MPh -

30.1

40.3

49.3

modified plan
The modified plan gave a pass rate of 49.3% for the dose difference of 4% and distance-to-agreement
of 3 mm, which was anticipated due to the simulated errors in afterloader delivery. Performing the
dose calculations and using the 2D gamma analysis to compare the dose profiles allowed for
additional verification of the treatment delivery, which could also be used to verify the dose
calculations of the treatment planning system.
5. Conclusion
The novel “magic phantom” system and software has demonstrated its ability to verify treatment
plans for HDR brachytherapy in terms of dwell position and times. Gross errors in source position and
timing above 1.3 mm and 0.3 s have been shown to be measurable using the new position-time
gamma index. The addition of a TG-43U1 calculation to the software allows for dosimetric
information to be determined based upon the measured treatment plan and was shown to be in
agreement with the TPS calculated values and with experimental EBT3 film results.
In future work, the “magic phantom” will be used to verify real patient plans and will translate
measured dwell positions and time patterns to 3D dose calculations, including contributions of dose
associated with source transition. The comparison of planned 3D doses by TPS and calculated values
will complement the innovative position-time gamma analysis and provide comprehensive QA of the
entire treatment delivery.
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